Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Lonapegsomatropin

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TransCon CNP Shows Gains in Achondroplasia at Week 26
    TransCon CNP Shows Gains in Achondroplasia at Week 26

    09 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/09/3095728/0/en/TransCon-hGH-Boosted-Treatment-Benefits-of-TransCon-CNP-in-Children-with-Achondroplasia-at-Week-26-Interim-Analysis-of-the-Phase-2-COACH-Trial.html

    GLOBENEWSWIRE
    09 Jun 2025
    Share Share
    New Therapy for Children with Growth Hormone Deficiency Approved
    New Therapy for Children with Growth Hormone Deficiency Approved

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-therapy-for-children-with-growth-hormone-deficiency-approved-in-australia-302468041.html

    PR NEWSWIRE
    28 May 2025
    Share Share
    New InsiGHTS Trial of TransCon™ hGH Achieves Primary Goal
    New InsiGHTS Trial of TransCon™ hGH Achieves Primary Goal

    16 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/16/2997524/0/en/New-InsiGHTS-Trial-of-TransCon-hGH-Lonapegsomatropin-in-Turner-Syndrome-Achieved-Primary-Objective-at-Week-26.html

    GLOBENEWSWIRE
    16 Dec 2024
    Share Share
    Vector Pharma FZCO Announce Agreement with Ascendis for Skytrofa
    Vector Pharma FZCO Announce Agreement with Ascendis for Skytrofa

    08 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/08/2805433/0/en/Vector-Pharma-FZCO-Announce-Exclusive-Distribution-Agreement-with-Ascendis-Pharma-A-S-for-Skytrofa-lonapegsomatropin-and-Yorvipath-palopegteriparatide-in-Gulf-Cooperation-Council-C.html

    GLOBENEWSWIRE
    08 Jan 2024
    Share Share
    TransCon Achieved Superior Outcomes Compared to Placebo in Ph 3 foresiGHt Trial
    TransCon Achieved Superior Outcomes Compared to Placebo in Ph 3 foresiGHt Trial

    19 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/19/2798534/0/en/TransCon-hGH-lonapegsomatropin-Achieved-Statistically-Superior-Outcomes-Compared-to-Placebo-in-Phase-3-foresiGHt-Trial-of-Adults-with-Growth-Hormone-Deficiency.html

    GLOBENEWSWIRE
    19 Dec 2023
    Share Share
    Ascendis Pharma Launches SKYTROFA in Germany
    Ascendis Pharma Launches SKYTROFA in Germany

    15 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/15/2743952/0/en/Ascendis-Pharma-Launches-SKYTROFA-lonapegsomatropin-in-Germany-for-the-Once-Weekly-Treatment-of-Children-and-Adolescents-with-Growth-Hormone-Deficiency.html

    GLOBENEWSWIRE
    15 Sep 2023
    Share Share